Selectivity Advantage: Unlike GHRP-2 and GHRP-6, which non-selectively activate multiple pituitary hormone pathways (ACTH, cortisol, prolactin), ipamorelin demonstrates minimal cross-reactivity with non-target pituitary receptors, making it pharmacologically similar to GHRH in its hormone-releasing selectivity
The 503A Bulks List identifies certain bulk drug substances that may be used in traditional patient-specific compounding when other statutory conditions are satisfied and no applicable monograph or approved-drug-component pathway applies
63 A case series linked the use of semaglutide or tirzepatide with an increased risk of NAION, sometimes after a single dose, including in one patient without diabetes and in another who experienced symptoms in both eyes following separate doses
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding
The decision to use compounded drugs is guided by the licensed provider's medical judgment, informed by a telehealth consultation and medical history." altRx also states that patients may receive medication that looks different than what is portrayed on the website
Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1
